The company was disappointed to step aside from Genesco post Q2 earnings, which saw its stock fall off a cliff, down 32 percent on the week.
"We are highly disappointed to be stepping aside on GCO, particularly since our positive view related to the multi-year Lids recovery is intact. However, the stunning comps falloff at Journeys provides too many uncertainties related to the timing and shape of a recovery," Baird said in an analyst noted released Friday.
What Went Wrong At Journeys?
The footwear retailer was able to correctly identify recent trends of casual/athletic footwear with adidas AG (ADR) (OTC: ADDYY) comeback along with PUMA SE NPV (OTC: PMMAF), but was "unable to secure adequate allocations to offset declines elsewhere (likely Vans VF Corp (NYSE: VFC)/Converse Nike Inc (NYSE: NKE)/Sperry Wolverine World Wide, Inc. (NYSE: WWW)), pressuring conversion despite reasonably solid traffic," Baird Analysts said. Comps were particularly troubling for Journeys, down 4 percent in the quarter.
Genesco stock was up 1 percent in midday trading Friday.
Full ratings data available on Benzinga Pro.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
